We are live on ! Find out more
SNTI icon

Senti Biosciences Holdings

44 hedge funds and large institutions have $207M invested in Senti Biosciences Holdings in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more ownership

Funds ownership: 0% → 88% (+88%)

Holders
44
Holders Change
+44
Holders Change %
–
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SNTI Hedge Fund Activity: Q2 2021 in Review

44 of the 5,771 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q2 2021, worth a combined $207M.

Buyers outnumbered sellers: 44 funds opened new SNTI positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $29.9M.

  • 44 institutional investors held Senti Biosciences Holdings (SNTI) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $207M of Senti Biosciences Holdings stock for Q2 2021.
  • 44 funds opened new Senti Biosciences Holdings positions in Q2 2021 and 0 closed out, a net change of +44 holders.
  • The largest Senti Biosciences Holdings buyer in Q2 2021 was T. Rowe Price Associates, an estimated $29.9M added.

Based on aggregated 13F filings for Q2 2021.